At a glance
ClinicalIndex Comparison RecordN/ACompleted· 91 enrolled
Drug / intervention
Device closure with the AMPLATZER Muscular VSD Occluderdevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Closure of Muscular Ventricular Septal Defects With The AMPLATZER™ Muscular VSD Occluder
In Brief
A clinical study evaluating Device closure with the AMPLATZER Muscular VSD Occluder for Heart Septal Defects, Ventricular. Completed, enrolled 91 participants across 11 sites.
Detailed Summary
The objective is to investigate the safety of the AMPLATZER Muscular VSD Occluder for the treatment of muscular ventricular septal defects, which are hemodynamically significant and are either isolated or in conjunction with other congenital heart defects in infants and children.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHeart Septal Defects, Ventricular
CountriesUnited States
Collaborators--
Timeline
N/ACompletedFinished
2000200120022003200420052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
Enrollment StartJul 2000
First PostedDec 2007
Primary CompletionOct 2008
Study CompletionNov 2009
TodayJul 2026
First PostedDec 31, 2007
Enrollment StartJul 1, 2000
Primary CompletionOct 1, 2008
Study CompletionNov 1, 2009
TodayJul 2, 2026
Enrollment to primary: 8.3 yearsPosted 18.5 years ago
Interventions
Device closure with the AMPLATZER Muscular VSD Occluderdevice
Device: AMPLATZER Muscular VSD Occluder